Trial · NCT06561958
Registered outcomes30
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 30
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cumulative live birth rate | Up to 12 months | Cumulative live birth rate defined as delivery of at least 1 live fetus after 20 completed weeks of gestation, combined fresh and frozen embryo transfers within 12 months after the start of the ovarian stimulation in patients of the first REKOVELLE ovarian stimulation cycle. |
| Secondary | The Luteinising hormone (LH) surge suppression protocol | Up to 22 days | Treatment pattern will be measured by analysing the Lutenising hormone (LH) surge suppression protocol. |
| Secondary | Daily Dosage | Up to 22 days | Treatment pattern will be measured by analysing the REKOVELLE and concomitant ovarian stimulation protocols, consisting of daily dosage. |
| Secondary | Stimulation Duration | Up to 22 days | Treatment pattern will be measured by analysing the REKOVELLE and concomitant ovarian stimulation protocols, consisting of stimulation duration. |
| Secondary | Total Dosage | Up to 22 days | Treatment pattern will be measured by analysing the REKOVELLE and concomitant ovarian stimulation protocols, consisting of total dosage. |
| Secondary | Trigger Protocol | Up to 22 days | Treatment pattern will be measured by analysing the trigger protocol. |
| Secondary | Luteal phase support protocol | Up to 22 days | Treatment pattern will be measured by analysing the luteal phase support protocol. |
| Secondary | Number of oocytes retrieved | Up to 22 days | Number of oocytes retrieved at oocyte retrieval |
| Secondary | Number of Metaphase II (MII) oocytes | Up to 22 days | Number of MII oocytes at oocyte retrieval (only applicable for Intracytoplasmic sperm injection (ICSI)) |
| Secondary | Number of embryos | Day 3 after oocyte retrieval | Number of embryos on Day 3 after oocyte retrieved |
| Secondary | Number of Blastocysts | Day 5 after oocyte retrieval | Number of Blastocysts on Day 5 after oocyte retrieved |
| Secondary | Number of embryos transferred | Up to 28 days | Embryos transferred in fresh and/or frozen transfer cycles |
| Secondary | Number of blastocysts transferred | Up to 28 days | Blastocysts transferred in fresh and/or frozen transfer cycles |
| Secondary | Implantation rate | Up to 28 days | Number of gestational sacs, embryos or blastocysts transferred |
| Secondary | Positive human chorionic gonadotropin (hCG) rate | 11 to 15 days after transfer | Positive human chorionic gonadotropin (hCG) rate analysed using serum or urine hCG test 11-15 days after transfer |
| Secondary | Clinical Pregnancy rate | 4 to 5 weeks after transfer | Clinical pregnancy rate (at least 1 gestational sac 4-5 weeks after transfer) |
| Secondary | Vital Pregnancy | 4 to 5 weeks after transfer | Vital pregnancy rate (at least 1 intrauterine gestational sac with fetal heartbeat 4-5 weeks after transfer) |
| Secondary | Ongoing pregnancy rate | 9 to 11 weeks after transfer | Ongoing pregnancy rate (at least 1 intrauterine viable fetus 9-11 weeks after transfer) |
| Secondary | Time to pregnancy | 4 to 5 weeks after transfer | Time to pregnancy from start date of ovarian stimulation to confirmation of clinical pregnancy |
| Secondary | Live birth rate | More than 20 weeks after transfer | Live birth is defined as delivery of at least 1 live fetus after 20 completed weeks of gestation within 12 months after the start of the ovarian stimulation in patients of the first REKOVELLE ovarian stimulation cycle. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06561958/registered